NEW YORK, Aug. 23, 2023 /PRNewswire/ — The Trustees of the Opioid Master Disbursement Trust II (the “Opioid MDT II”) issued a statement today regarding drugmaker Mallinckrodt filing for a second bankruptcy and reaching a debt reduction deal: “The Opioid MDT II Trustees made a difficult…
Statement on Behalf of the Trustees of the Opioid Master Disbursement Trust II (the “Opioid MDT II”)
This post was originally published on this site